This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universität Zu Koln. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Lynnette Fernandez-Cuesta: Innovator in Cancer Research
Introduction
Lynnette Fernandez-Cuesta is a prominent inventor based in Lyons, France. She has made significant contributions to the field of cancer research, particularly through her innovative work on fusion genes.
Latest Patents
Lynnette holds a patent for her invention titled "NRG1 fusion genes in cancer." This groundbreaking invention relates to novel fusion genes that comprise NRG1 and a further fusion partner, such as CD74. The patent outlines the use of these fusion genes in both diagnosis and medical intervention for cancer, showcasing her commitment to advancing cancer treatment.
Career Highlights
Lynnette is affiliated with the University of Cologne, where she continues her research and development in the field of oncology. Her work has garnered attention for its potential impact on cancer diagnostics and therapies.
Collaborations
Lynnette has collaborated with notable colleagues, including Julie George and Dennis Plenker, further enhancing her research efforts and contributions to the scientific community.
Conclusion
Lynnette Fernandez-Cuesta is a trailblazer in cancer research, with her innovative patent on NRG1 fusion genes paving the way for advancements in diagnosis and treatment. Her work exemplifies the vital role of inventors in the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile